Page last updated: 2024-10-17

bupropion and Amblyopia

bupropion has been researched along with Amblyopia in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Amblyopia: A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, CC1
Tsai, CY1
Tsai, TH1
Tsai, IJ1

Other Studies

1 other study available for bupropion and Amblyopia

ArticleYear
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
    Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with

2019